See every side of every news story

Published 22 hours ago • loading... • Updated 14 hours ago

GLP-1 receptor agonists linked to lower mortality for patients with brain metastases, T2DM

Summary by Medical Xpress

For patients with cancer and brain metastases (BM) and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with significantly lower all-cause mortality, according to a research letter published online March 11 in JAMA Network Open.

2 Articles

2 Articles

GLP-1 receptor agonists linked to lower mortality for patients with brain metastases, T2DM

For patients with cancer and brain metastases (BM) and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with significantly lower all-cause mortality, according to a research letter published online March 11 in JAMA Network Open.

1 day ago

Read Full Article

European Medical Journal

GLP-1RAs Can Benefit Patients with Brain Cancer and Type 2 Diabetes

The post GLP-1RAs Can Benefit Patients with Brain Cancer and Type 2 Diabetes appeared first on European Medical Journal.

14 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left0Leaning Right0Center1Last Updated9 hours agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in 1 day ago on Saturday, March 14, 2026.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics